Vietnam to make anti-measles and rubella vaccines

A state-owned Vietnamese pharmaceutical company is preparing to produce anti-measles and anti-rubella vaccines from May this year.

The Center for Research and Production of Vaccines (POLYVAC), under the Ministry of Health, will coordinate with Japan International Cooperation Agency (JICA) for a five-year project to produce anti-measles and anti-rubella vaccines at an investment cost of US$7.51 million.

JICA experts will transfer technology and provide training to Vietnamese staff on vaccine manufacturing technology in Japan. JICA will also give financial assistance to POLYVAC to build a manufacturing plant for the vaccine, and continue supplying equipment to the Center for future projects.

By 2017, it is hoped that the country will have full grasp of the vaccine making technology and by 2018 the vaccine will be available in the market and become part of the National Extended Program for Immunization.

The domestic production of these vaccines is in response to the country’s need and aim to reduce reliance on foreign made vaccines and at being self-sufficient in combating diseases.

By Quoc Lap – Translated by Uyen Phuong

Other news